ReviewJRSM cardiovascular disease
Myocardial remodelling and recovery in dilated cardiomyopathy.
Review in JRSM cardiovascular disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 32 citations in OpenAlex.
- Genetic Profiling and Phenotype Spectrum in a Chinese Cohort of Pediatric Cardiomyopathy Patients.Journal of cardiovascular development and disease · 2025Article
- Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy.European journal of heart failure · 2025Observational
- Myocardial Recovery and Relapse in Heart Failure With Improved Ejection Fraction.Current treatment options in cardiovascular medicine · 2024Article
- Design and Analysis of a Polymeric Left Ventricular Simulator via Computational Modelling.Biomimetics (Basel, Switzerland) · 2024Article
- Myocardial Recovery in Cardiogenic Shock.Methodist DeBakey cardiovascular journal · 2024Review
- The potential predictive value of cardiac mechanics for left ventricular reverse remodelling in dilated cardiomyopathy.ESC heart failure · 2023Article
- DCM-PROGRESS: predicting end-stage heart failure in non-ischemic dilated cardiomyopathy patients.medRxiv : the preprint server for health sciences · 2023Article
- Native T1 high region and left ventricular ejection fraction recovery in patients with dilated cardiomyopathy.The international journal of cardiovascular imaging · 2023Article
- The complete reversal effect following angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and beta-blockers after the primary diagnosis of dilated cardiomyopathy.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2023Article
- Prognostic implications of left ventricular ejection fraction trajectory changes in heart failure.Frontiers in cardiovascular medicine · 2023Article
- Characteristics and outcomes of heart failure with recovered left ventricular ejection fraction.ESC heart failure · 2021Article
- Diagnosis and Risk Prediction of Dilated Cardiomyopathy in the Era of Big Data and Genomics.Journal of clinical medicine · 2021Review
- Late gadolinium enhancement for re-worsening left ventricular ejection fraction in patients with dilated cardiomyopathy.ESC heart failure · 2021Article
- Early Prediction of Left Ventricular Reverse Remodeling in First-Diagnosed Idiopathic Dilated Cardiomyopathy: A Comparison of Linear Model, Random Forest, and Extreme Gradient Boosting.Frontiers in cardiovascular medicine · 2021Article
- Differential Expression Profiles and Functional Analysis of Long Non-coding RNAs in Children With Dilated Cardiomyopathy.Frontiers in pediatrics · 2021Article
- Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition.Cardiac failure review · 2020Review
- Wisteria floribunda agglutinin staining for the quantitative assessment of cardiac fibrogenic activity in a mouse model of dilated cardiomyopathy.Laboratory investigation; a journal of technical methods and pathology · 2019Article
- DNA Damage Prediction Tool in Dilated Cardiomyopathy: Don't Go Breaking My Heart.JACC. Basic to translational science · 2019Article
- Quantification of DNA Damage in Heart Tissue as a Novel Prediction Tool for Therapeutic Prognosis of Patients With Dilated Cardiomyopathy.JACC. Basic to translational science · 2019Article
- Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure.Internal and emergency medicine · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Myocardial reverse remodeling has been reported to occur in 25-70% of patients with dilated cardiomyopathy. It is not yet fully understood whether remodeling represents disease remission or cure and which hearts retain this capacity to recover. In this review article we discuss the capacity for recovery in DCM, the prognostic implications of this recovery and potential clinical and imaging predictors for myocardial remodeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.